Patents by Inventor Benjamin J. Zeskind

Benjamin J. Zeskind has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120066171
    Abstract: The disclosure relates to methods of predicting the effects of therapy, designing/conducting a clinical trial, selecting a subject for a clinical trial, selecting a subject for therapy, monitoring a subject's responsiveness to therapy, treating a subject, and predicting effects of anti-CD25 therapy.
    Type: Application
    Filed: September 7, 2011
    Publication date: March 15, 2012
    Applicant: Immuneering Corporation
    Inventor: Benjamin J. Zeskind
  • Publication number: 20100318301
    Abstract: A method and system for determining the extent to which a patient will respond to a therapeutic regimen by assessing how that regimen will impact the functioning of a patient's immune system. An extent to which a patient will respond to a therapeutic regimen may be assessed based on a set of values for measurable parameters that relate to one or more characteristics of the patient's immune system, and receptor-ligand binding and trafficking characteristics of the patient's immune system, as well as other optional parameters and characteristics of the immune system. A mathematical model of the immune system is provided and may be implemented to predict immune system response, as well as identify parameters that have a greatest impact on predicting immune system response.
    Type: Application
    Filed: July 14, 2010
    Publication date: December 16, 2010
    Inventor: Benjamin J. Zeskind
  • Publication number: 20100310511
    Abstract: Methods for analyzing one or more elements, markers, ligands or other characteristics of the immune system of a body (e.g., of a human or other animal), and based on the analysis, determine a location of disease, identify immune system failure, and/or determine treatments based on disease location or immune system failure. All or a part of the immune system process may be analyzed to identify specific features of the immune system, e.g., which may indicate that the disease will evade the immune system and produce a negative outcome. Therapy may be employed to correct immune system failure rather than addressing the disease directly.
    Type: Application
    Filed: March 5, 2010
    Publication date: December 9, 2010
    Applicant: Immuneering Corporation
    Inventor: Benjamin J. Zeskind
  • Patent number: 7491943
    Abstract: A method and apparatus for illuminating a subject with deep UV light and detecting 2-dimensional image information, e.g., a transmission image, fluorescence image, reflected light image, etc. The subject may be illuminated with a light pulse having a duration of 2 seconds or less and one or more components with a wavelength of between about 150 nm to about 300 nm. The light pulse may be arranged so as to minimize or eliminate any detrimental effect on the functioning of the subject, e.g., on a living cell. A concentration, mass, quantum yield, absorbance or other characteristics of one or more compounds in the subject may be determined based on one or more 2-dimensional images obtained of the subject. An illumination beam having left and right circularly polarized components may be generated, e.g., for circular dichroism analysis of a subject.
    Type: Grant
    Filed: January 13, 2006
    Date of Patent: February 17, 2009
    Assignees: Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology
    Inventors: Benjamin J. Zeskind, Paul Matsudaira, Daniel Ehrlich
  • Patent number: 7335874
    Abstract: A method and apparatus for illuminating a subject with deep UV light and detecting 2-dimensional image information, e.g., a transmission image, fluorescence image, reflected light image, etc. The subject may be illuminated with a light pulse having a duration of 2 seconds or less and one or more components with a wavelength of between about 150 nm to about 300 nm. The light pulse may be arranged so as to minimize or eliminate any detrimental effect on the functioning of the subject, e.g., on a living cell. A concentration, mass, quantum yield, absorbance or other characteristics of one or more compounds in the subject may be determined based on one or more 2-dimensional images obtained of the subject. An illumination beam having left and right circularly polarized components may be generated, e.g., for circular dichroism analysis of a subject.
    Type: Grant
    Filed: January 13, 2006
    Date of Patent: February 26, 2008
    Assignees: Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology
    Inventors: Benjamin J. Zeskind, Paul Matsudaira, Daniel Ehrlich